Olink vs SomaLogic SomaScan
Since April 2025, 262 bioRxiv and medRxiv preprints say they used Olink and 127 SomaScan; 14 used both. Updated daily (as of Nov 16)
Olink is used 2.7x more often than SomaScan.
In Jun–Nov 2026, 92 preprints said they used Olink, and 34 SomaLogic SomaScan.
Olink is growing faster.
In Jun–Nov 2026 vs the previous year, as a share of all preprints, Olink grew 30% and SomaLogic SomaScan shrank 22%.
Olink
SomaScan
The last bar is the quarter so far.
Which preprints have used both Olink and SomaLogic SomaScan?
14 preprints since April 2025 say they used both Olink and SomaLogic SomaScan. That's 11% of the 127 preprints using SomaScan and 5% of the 262 using Olink.
Latest preprints using Olink
Latest preprints using SomaScan
Which institutions use Olink and SomaLogic SomaScan most?
Labs at Karolinska Institutet, Icahn School of Medicine at Mount Sinai and University of Oxford use Olink most; at Stanford University, University of California, San Francisco and Washington University in St. Louis, SomaLogic SomaScan. The lab's institution is the corresponding author's.
Olink Thermo Fisher
Where the labs are
Institutions using it most
Karolinska Institutet12
Icahn School of Medicine at Mount Sinai7
University of Oxford5
University of California, San Francisco5
Fields
Immunology 42Neurology 26Cardiovascular medicine 18Genetic and genomic medicine 14
SomaScan SomaLogic (Illumina)
Where the labs are
Institutions using it most
Stanford University8
University of California, San Francisco5
Washington University in St. Louis5
University of California, San Diego5
Fields
Neurology 21Neuroscience 11Immunology 10Epidemiology 10
How we count which preprints use each platform
An AI model reads each preprint in full — its text, its tables and its supplementary files — and lists the products the authors used. A preprint counts for a platform when that record says the lab used it in this work, not when it only analyzed data others made with it or only mentioned it. Each preprint counts once, by its first version, if it was first posted on bioRxiv or medRxiv in April 2025 or later. We read new preprints within days of posting, so the newest ones (through Nov 16, 2026) are already counted, but those days are not complete yet. Six-month counts and growth figures stop at Nov 12, 2026, the last day nearly every preprint has been read, and charts draw a quarter that is still being counted in a paler color. A preprint that used two platforms counts for both. This page counts how often each platform is used in preprints. It does not show which is better, or market share. Each title links to the preprint on bioRxiv or medRxiv; we show no preprint text and no author names. Updated daily, most recently on Nov 16, 2026.